—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Biomarin Pharmaceutical Inc (BMRN) — Technical state

As of 2026-11-05 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Mixed moving-average stack — Trades -6.3% vs the 50-day and -4% vs the 200-day average, 20.9% below the 52-week high and +13.9% off the 52-week low; a golden cross printed 76 sessions ago. Computed from daily closes. (as of 2026-11-05)
  • Trend: Biomarin Pharmaceutical Inc trades 6.3% below its 50-day and 4.0% below its 200-day moving average. (as of 2026-11-05)

BioMarin develops and sells enzyme-replacement and other therapies for rare genetic diseases, including VIMIZIM, NAGLAZYME, PALYNZIQ, BRINEURA and ALDURAZYME, plus VOXZOGO for achondroplasia and KUVAN for phenylketonuria. It also runs an early pipeline that includes BMN 333, a longer-acting growth-disorder candidate, and BMN 351 for Duchenne muscular dystrophy.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the BMRN overview. Research diary readings, not advice.

Mixed moving-average stack

Trades -6.3% vs the 50-day and -4% vs the 200-day average, 20.9% below the 52-week high and +13.9% off the 52-week low; a golden cross printed 76 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the BMRN chart & overview · the signal board

FAQ · from the current data · as of 2026-11-05

Quick answers

What is the current Closelooknet signal on BMRN?

Mixed moving-average stack — Trades -6.3% vs the 50-day and -4% vs the 200-day average, 20.9% below the 52-week high and +13.9% off the 52-week low; a golden cross printed 76 sessions ago. Computed from daily closes. As of 2026-11-05; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is BMRN above its 50-day and 200-day moving averages?

As of 2026-11-05, Biomarin Pharmaceutical Inc trades -6.3% below its 50-day and -4% below its 200-day average, with the 20-day +0.3% away.

How far is BMRN from its 52-week high?

20.9% below the 52-week high and 13.9% above the 52-week low, as of 2026-11-05.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.